IRIS
CORREALE, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.903
EU - Europa 2.715
AS - Asia 2.205
SA - Sud America 365
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.837
SG - Singapore 904
IE - Irlanda 643
CN - Cina 586
RU - Federazione Russa 556
SE - Svezia 368
BR - Brasile 297
UA - Ucraina 276
HK - Hong Kong 242
DE - Germania 202
VN - Vietnam 175
FR - Francia 172
IT - Italia 170
IN - India 93
FI - Finlandia 80
AT - Austria 66
GB - Regno Unito 56
CZ - Repubblica Ceca 43
TR - Turchia 37
CA - Canada 34
BD - Bangladesh 30
IQ - Iraq 25
AR - Argentina 22
NL - Olanda 22
MX - Messico 21
ZA - Sudafrica 21
PK - Pakistan 20
ES - Italia 17
PL - Polonia 14
TN - Tunisia 13
PH - Filippine 12
EC - Ecuador 11
JP - Giappone 11
VE - Venezuela 10
UZ - Uzbekistan 9
KE - Kenya 8
LT - Lituania 7
PE - Perù 7
BE - Belgio 6
CL - Cile 6
DZ - Algeria 6
MA - Marocco 6
OM - Oman 6
AZ - Azerbaigian 5
CO - Colombia 5
EG - Egitto 5
ID - Indonesia 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
JO - Giordania 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
TH - Thailandia 4
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EU - Europa 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
PS - Palestinian Territory 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 8.261
Salva come PNG Salva come JPEG
Città #
Dublin 643
San Jose 595
Ashburn 431
Singapore 416
Hong Kong 238
Nyköping 233
Beijing 190
Chandler 187
Jacksonville 171
Dallas 158
Santa Clara 113
Munich 103
Lauterbourg 102
Dearborn 72
New York 68
Nanjing 61
Princeton 61
Vienna 59
Los Angeles 55
Moscow 55
Ho Chi Minh City 54
The Dalles 48
Wilmington 45
Hanoi 44
Helsinki 42
Frankfurt am Main 36
Seattle 31
Boardman 30
Brno 28
Turku 25
Falkenstein 22
Nanchang 22
Pune 22
São Paulo 20
London 19
Guangzhou 17
San Mateo 17
Rome 16
Hillsboro 15
Nuremberg 15
Olomouc 15
Tianjin 15
Des Moines 14
Shanghai 14
Atlanta 13
Brooklyn 13
Johannesburg 13
San Francisco 13
Assago 12
Chennai 12
Council Bluffs 12
Düsseldorf 12
Warsaw 12
Jiaxing 11
Shenyang 11
Toronto 11
Da Nang 10
Mumbai 10
Palermo 10
Amsterdam 9
Changsha 9
Foggia 9
Haiphong 9
Hangzhou 9
Montreal 9
Boston 8
Jinan 8
Milan 8
Nairobi 8
Orem 8
Renton 8
Tashkent 8
Tokyo 8
Tunis 8
Washington 8
Baghdad 7
Dhaka 7
Kunming 7
Lund 7
Stevenage 7
Woodbridge 7
Ann Arbor 6
Bari 6
Brussels 6
Denver 6
Gesualdo 6
Hebei 6
Mexico City 6
Philadelphia 6
Shenzhen 6
Acerra 5
Belo Horizonte 5
Chicago 5
Curitiba 5
Karachi 5
Ningbo 5
Norwalk 5
Paris 5
Phoenix 5
Portsmouth 5
Totale 5.092
Salva come PNG Salva come JPEG
Nome #
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 141
Alcohol-induced cardiac disease 138
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 137
EXPRESS: Don't stop at first glance; pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension 132
"PAFIYAMA" syndrome; further evidence on a novel clinical entity 131
Delirium in heart failure 125
Late onset of coronary vasospasm after administration of methyl-ergometrine for gynecologic bleeding. 124
Cardiopulmonary exercise test predicts right heart catheterization 124
Typical Takotsubo syndrome and McConnell's phenomenon: What else lies beneath? 117
Influence of Heart Rate on Left and Right Ventricular Longitudinal Strain in Patients with Chronic Heart Failure 117
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability 116
Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: data from the Daunia Registry 115
Liver disease and heart failure: Back and forth 115
Chronic thromboembolic pulmonary hypertension. 112
Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia 112
Inferior ST-Elevation Acute Myocardial Infarction or an Inferior-Lead Brugada-like Electrocardiogram Pattern Associated With the Use of Pregabalin and Quetiapine? 110
Biomarkers in cardiorenal syndrome 110
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis 106
Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure 105
Tako-Tsubo cardiomyopathy in a teen girl with pheochromocytoma. 105
Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy 104
Fenofibrate and Dyslipidemia: Still a Place in Therapy? 104
Liver disease and heart failure: an uptodate 104
New Targets in Heart Failure Drug Therapy 104
Recurrent Tako-Tsubo cardiomyopathy apparently induced by opposite triggers 103
Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis 103
"ischemic" ST elevation in a woman with left ventricular hypertrophy 97
Novel AKAP9 mutation and long QT syndrome in a patient with torsades des pointes 97
Redefining biomarkers in heart failure 96
Cardiac contractility modulation in left ventricular systolic dysfunction: trick or treat? 96
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure 96
Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction 95
Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan 94
Tako-Tsubo cardiomyopathy recurrence in an elderly woman firstly diagnosed with acute myocardial infarction: How many cold cases to be reclassified? 92
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 92
Advanced heart failure: non-pharmacological approach 91
Echocardiographic score for prediction of pulmonary hypertension at catheterization: The Daunia Heart Failure Registry 91
Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure 91
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 90
SAT0325 Nailfold capillaroscopic changes in patients with idiopathic and systemic sclerosis-related pulmonary arterial ipertension 89
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry 89
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: Where do we stand? 89
Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use? 88
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 88
COMPASS vs PEGASUS approach in a comparative budget impact analysis 87
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic 87
Delirium in heart failure 86
Effects of Sacubitril/Valsartan on the Renal Resistance Index 85
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry 85
Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation 84
Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease 84
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management 81
HIV-associated pulmonary arterial hypertension: from bedside to the future 80
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 80
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization 78
Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure 78
The thromboembolism in COVID-19: the unsolved problem 76
Tako-Tsubo cardiomyopathy or allergic acute coronary syndrome: that is the question. 74
Impact of Frailty on Outcome of Older Patients With Non-ST Elevation Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention 70
Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers 69
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches 69
Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction 69
Gastrointestinal bleeding and coagulation disorders in a patient with left-ventricular assist device 68
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction 67
Biomarker profiles that differentiate type-1 and type 2 myocardial infarction 67
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy 65
Switch to Gliflozins and Biventricular Function Improvement in Patients with Chronic Heart Failure and Diabetes Mellitus 65
Relationship between the strain measures of left atrial function and heart failure worsening 64
Atrial paced rhythm and heart rate-dependent worsening of left atrial and ventricular function 64
Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction 64
Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patients 63
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies 63
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 62
Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets 61
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan 61
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 60
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 60
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study) 60
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension 60
Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender 60
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 59
LEAP Virtual Visit Assessment (VIVA): A structured protocol for virtual visits for patients with heart failure 59
Endothelial Function Correlates With Pulmonary Pressures in Subjects With Clinically Suspected Pulmonary Hypertension 58
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 58
SGLT2 Inhibitors Introduction and Changes of the Other Disease Modifiers’ Drugs in Heart Failure Patients: A Single Center Real World Experience 56
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 56
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 56
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 55
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach 55
Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging 54
Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside 54
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 53
Acute coronary syndrome with single‑lead ST segment elevation: A rare presentation of multivessel coronary artery disease 53
Alcohol consumption and subclinical and clinical coronary heart disease: New insight into potential causal mechanisms 51
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience 49
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century? 48
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 48
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 47
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients 46
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF 44
Totale 8.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.767
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 56 1 0
2021/2022412 17 2 11 3 70 14 11 38 49 86 6 105
2022/20231.331 117 69 83 38 31 104 2 86 702 10 40 49
2023/2024585 57 18 39 19 79 124 13 94 1 11 14 116
2024/20251.735 88 18 28 77 50 243 159 115 456 153 198 150
2025/20263.446 310 321 444 304 194 186 720 433 316 218 0 0
Totale 8.646